Shyam K. Tanguturi, MD
Physician, Cancer and Blood Disorders Center
Instructor of Radiation Oncology, Harvard Medical School
Image
Shyam K. Tanguturi, MD
Physician, Cancer and Blood Disorders Center
Instructor of Radiation Oncology, Harvard Medical School
Medical Services
Education
Medical School
Harvard Medical School
Boston
MA
Residency
Physician, Cancer and Blood Disorders Center
Boston
MA
Publications
Evaluating Adjuvant Radiation Therapy for Grade 2 Meningioma: A Multi-Institutional Analysis. View Abstract
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis. View Abstract
PD-L1, Tumor Mutational Burden, and Outcomes in NSCLC With Brain Metastases: A Brief Report. View Abstract
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma. View Abstract
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypes. View Abstract
Progestin-associated meningiomatosis with unusual schwannoma-like morphology. View Abstract
Clinical Outcomes Among Patients Treated With Stereotactic Body Radiation Therapy to Femur Metastases for Oligometastatic Disease Control or Reirradiation: Results From a Large Single-Institution Experience. View Abstract
Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence. View Abstract
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. View Abstract
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression. View Abstract
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity. View Abstract
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries. View Abstract
Comparison of MR-soft tissue based versus biliary stent based alignment for image guidance in pancreatic SBRT. View Abstract
Patient specific distortion detection and mitigation in MR images used for stereotactic radiosurgery. View Abstract
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort. View Abstract
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation. View Abstract
Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. View Abstract
Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study. View Abstract
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly. View Abstract
Quantifying the impact of surgical decompression on quality of life and identification of factors associated with outcomes in patients with symptomatic metastatic spinal cord compression. View Abstract
The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer. View Abstract
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases. View Abstract
Local control after brain-directed radiation in patients with cystic versus solid brain metastases. View Abstract
Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis. View Abstract
Neurologic Complications of Radiation Therapy. View Abstract
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. View Abstract
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype. View Abstract
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma. View Abstract
Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose? View Abstract
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. View Abstract
Hypofractionation for Early-Stage Breast Cancer: No More Excuses. View Abstract
In Reply to Levra et al. View Abstract
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer. View Abstract
Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment. View Abstract
Radiotherapy for liver tumors. View Abstract
Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. View Abstract
Outcomes of proton therapy for patients with functional pituitary adenomas. View Abstract
Radiation therapy for liver tumors: ready for inclusion in guidelines? View Abstract
Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort. View Abstract
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. View Abstract
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. View Abstract
A new double-lumen tube adapter. View Abstract
Locations